← FDA DRUG APPROVALS

FDA ANDA · ANDA204633

ACITRETIN

Sponsor: SIGMAPHARM LABS LLC

APPLICATION
ANDA204633
TYPE
ANDA
ORIGINAL APPROVAL
2015-05-22
LATEST ACTION
2018-04-19
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ACITRETINPrescription
ACITRETIN 22.5MG · CAPSULE · ORAL
ACITRETINPrescription
ACITRETIN 10MG · CAPSULE · ORAL
ACITRETINPrescription
ACITRETIN 25MG · CAPSULE · ORAL
ACITRETINPrescription
ACITRETIN 17.5MG · CAPSULE · ORAL

Approval history

2018-04-19Labeling · Supplement 4 · standardAP
2015-10-06Labeling · Supplement 1 · standardAP
2015-05-22UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →